مقالات سایر پژوهشگران پژوهشکده سل و بیماری های ریوی در حوزه سرطان
|
ردیف |
نام مقاله |
مجله |
ایندکس |
نویسندگان |
|
1 |
"Primary pleuropulmonary synovial sarcoma: report of two cases and a comprehensive review of the literature." |
Cancer Investigation |
ISI |
Khalili, Neda, Elham Askari, Nastaran Khalili, Aboulghasem Daneshvar-Kakhki, Makan Sadr, Sara Haseli, and Mihan Pourabdollah Toutkaboni. |
|
2 |
A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation |
Cell Biology International |
ISI |
Gowhari Shabgah, A., Jadidi-Niaragh, F., Ebrahimzadeh, F., Ebrahimi Nik, M., Gholizadeh Navashenaq, J. |
|
3 |
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy |
Current Therapeutic Research - Clinical and Experimental |
ISI |
Shahi, F., Vafaeezadeh, F., Ansarinejad, N.,Babakhani, D., Anjidani, N. |
|
4 |
Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis |
International Journal of Cancer Management |
ISI |
Arezo Shahi , Naghmeh Bahrami , Robab Rafiei Tabatabaei , Mehdi Kazempour Dizaji , |
|
5 |
Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit |
Asian Pacific Journal of Cancer Prevention |
PubMed |
Seifi, S., Salimi, B., Esfahani-Monfared, Z., Talebianpour, S., Khosravi, A. |
|
6 |
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial |
BMC Cancer |
ISI |
Allahyari, A., Ehsanpour, A., Ansarinejad, N., Kafi, H., Najafi, S. |
|
7 |
Comparing the Quality of Life and General Health Status in Thoracic Cancer Patients with their Family Caregivers in Iran |
Tanaffos |
Pubmed |
Kosar Najmi , Habib Emami , Sharare Seifi , Adnan Khosravi , Alireza Ilbeigi , Vida Mortezaee , Somayeh Lookzadeh, Maral Emami, Hamidreza Jamaati , Ali Akbar Velayati |
|
8 |
Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line |
International Immunopharmacology |
ISI |
Ali Asadirad , Kaveh Baghaei , Seyed Mahmoud Hashemi , Sajad Dehnavi , Hossein Ghanbarian , Esmaeil Mortaz , Ali Anissian , Hamid Asadzadeh Aghdaei , Davar Amani |
|
9 |
Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study |
Supportive Care in Cancer |
ISI |
Jenabian, A., Ehsanpour, A., Mortazavizadeh, S.M.R., Anjidani, N., Kafi, H. |
|
10 |
Evaluation of Lymph Node Metastasis in Invasive Micropapillary Breast Carcinoma and Other Its Related Variables |
International Journal of Cancer Management |
ISI |
Ahadi, M., Askari, E., Zham, H., Zahedifard, S. |
|
11 |
Evaluation of the local and circulating expression level of cannabinoid receptor 2 in patients with lung cancer |
Gene Reports |
ISI |
Hosami, F., Salimi, V., Safizadeh, B., Ghadimkhah, M.H., Tavakoli-Yaraki, M. |
|
12 |
Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients |
Iranian Journal of Radiology |
Scopus |
Doroudinia, A., Darvishian, N., Karam, M.B., Emami, H. |
|
13 |
Exosomal circular RNA: a signature for lung cancer progression |
CANCER CELL INTERNATIONAL |
ISI |
Hussen, Bashdar Mahmud-Abdullah, Snur Rasool-Faraj, Goran Sedeeq Hama-Rasul, Mohammed Fatih-Salihi, Abbas-Ghafouri-Fard, Soudeh-Taheri, Mohammad-Mokhtari, Majid |
|
14 |
Expression of miRNA1, miRNA133, miRNA191, and miRNA24, as Good Biomarkers, in Non-Small Cell Lung Cancer Using Real-Time PCR Method |
Asian Pacific Journal of Cancer Prevention |
scopus |
Dizaji, M.K., Farzanegan, B., Bahrami, N., ...Rekabi, M., Mohamadnia, A. |
|
15 |
Impact of Various Image Reconstruction Methods on Joint Compensation of Respiratory Motion and Partial Volume Effects in Whole-Body18F-FDG PET/CT Imaging: Patients with Non-Small Cell Lung Cancer |
Iranian South Medical Journal |
Other |
Ghafarian P, Rezaei S, Gharepapagh E, Sarkar S, Ay M R |
|
16 |
Increasing or decreasing the expression of miR-199, miR-210 and miR-143 and the effect on cell growth, apoptosis and angiogenesis through the expression of target genes in non-small cell lung cancer |
Minerva Respiratory Medicine |
ISI |
Talischi, M.H., Mohamadnia, A., Mahmoodi, M., Bahrami, N., Farhadi Nasab, A. |
|
17 |
Inflammatory Potential of Diet and Odds of Lung Cancer: A Case-Control Study |
Nutrition and Cancer |
ISI |
Sadeghi, A., Parastouei, K., Seifi, S., ...Rasekhi, H., Amini, M. |
|
18 |
Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance |
International Journal of Biological Macromolecules |
ISI |
Shirvani, H.a , Jafari, H.b , Moravveji, S.S.c , Abbasi Faranghizadeh, F.d , Talebi, M.e , Ghanavi, J.f , Esfandi, F.g , Najafi, S.h , |
|
19 |
Organ Procurement from Potential Donors with a History of COVID-19 Vaccination |
Tanaffos |
Pubmed |
Fariba Ghorbani, Keihan Mostafavi, Mojtaba Mokhber Dezfuli |
|
20 |
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy |
Current Therapeutic Research |
ISI |
Shahi, F., Vafaeezadeh, F., Ansarinejad, N., ...Babakhani, D., Anjidani, N. |
|
21 |
Predictive Molecular Blood Biomarkers in Non-Small Cell Lung Cancer |
Journal of Cellular and Molecular Anesthesia |
Scopus |
Mohammad Hoseine Talischi Abdolreza Mohamadnia Minoo Mahmoodi Naghmeh Bahrami Abdollah Farhadi Nasab |
|
22 |
Primary Pleuropulmonary Synovial Sarcoma: Report of Two Cases and a Comprehensive Review of the Literature |
Cancer Investigation |
ISI |
Khalili, N., Askari, E., Khalili, N., ...Haseli, S., Pourabdollah Toutkaboni, M. |
|
23 |
Serous Borderline Tumor of the Fallopian Tube: A Case Report and |
Journal of Obstetrics, Gynecology and Cancer Research |
scopus |
ganjoei Tahereh Ashrafi.talayeh maryam.afsharmogghadam noushin.norouzi ali reza. Teymoordash. somayyeh noei. |
|
24 |
Synergistic impact of motion and acquisition/reconstruction parameters on 18F-FDG PET radiomic features in non-small cell lung cancer: Phantom and clinical studies |
Medical Physics |
ISI |
Hosseini, S.A., Shiri, I., Hajianfar, G., Zaidi, H., Ay, M.R. |
|
25 |
Synergistic inhibitory effect of human umbilical cord matrix mesenchymal stem cells-conditioned medium and atorvastatin on MCF7 cancer cells viability and migration |
Cell and Tissue Banking |
ISI |
Abolghasemi, R., Ebrahimi-Barough, S., Mohamadnia, A., Ai, J. |
|
26 |
The miR-196a SNP Rs11614913 but not the miR-499 rs37464444 SNP is a Risk Factor for Non-small Cell Lung Cancer in an Iranian Population |
Tanaffos |
Pubmed |
Dezfuli, N.K., Adcock, I.M., Alipoor, S.D., Salimi, B., Seyfi, S., Chehrazi, M., Varahram, M., Mortaz, E. |
|
27 |
Value of a18 F-FDG PET/CT Semi-quantitative Parameter (SUVmax) in Predicting the Survival of Patients with Esophageal Cancer Subtypes |
Iranian Journal of Radiology |
ISI |
Balkhkanlou, H.E., Doroudinia, A., Karam, M.B., Emami, H. |
|
28 |
Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment |
Progress in Biophysics and Molecular Biology |
ISI |
Vesaghhamedani, S., Ebrahimzadeh, F., Najafi, E., Shabgah, O.G., Askari, E., Shabgah, A.G., Mohammadi, H., Jadidi-Niaragh, F., Navashenaq, J.G. |